-
The spread of bone metastases is related to bone remodeling
Time of Update: 2022-10-31
Bones are often affected by metastasis, and in a recent study published in the journal Cancer Discovery, a team led by researchers at Baylor College of Medicine showed in animal models that the onset of bone metastases is combined with normal bone repair processes.
-
European Radiology: Application of multiparametric bone MRI in the selection of biopsy targets for bone metastases
Time of Update: 2022-08-12
. This study demonstrates that mpBMRI using a combination of DWI signal, ADC, and rFF can identify active bone metastases suitable for biopsy, while providing high diagnostic yield and NGS feasibility for use as part of interventional imaging efforts in patients with bone metastases Biopsy lesion selection in cancer patients .
-
Science Advances: mRNA technology enters new field: used to treat fractures and bone defects, promote bone regeneration
Time of Update: 2022-03-05
Recently, researchers from the Mayo Clinic in the United States published a research paper entitled: Efficient healing of large osseous segmental defects using optimized chemically modified messenger RNA encoding BMP-2 in the journal Science Advances .
-
JCEM: The relationship between anti-bone resorption agents and osteonecrosis of the jaw in patients with benign and malignant bone diseases
Time of Update: 2022-01-08
Preventive managementCompared with patients with benign bone disease, patients with advanced malignant tumors are at a much higher risk of developing MRONJ, because individuals with general poor health will use higher doses and more frequent anti-bone resorption agents, as well as other easy The combined drug that led to MRONJ .
-
Nature sub-publication reveals how bone cells form key structures that maintain bone health
Time of Update: 2021-11-14
In their study, the researchers found that the loss of the Sp7 gene in bone cells can cause severe defects in the dendrites of bone cells .
The research team discovered that the Sp7 transcription factor targets a gene called osteoctrin, which promotes the formation of bone cell dendrites .
-
JNCCN: The relationship between bone metastasis, bone-related events and survival in patients
Time of Update: 2021-05-20
Bone metastasis at baseline is a poor prognostic factor for ICIs in the treatment of metastatic NSCLC, and the application of BMAs cannot prevent the occurrence of SREs and improve the prognosis of patients.
-
JCEM: The effect of testosterone therapy on male bone microstructure and bone density
Time of Update: 2021-03-30
gov/33693907/" target="_blank" rel="noopener">Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT .
gov/33693907/" target="_blank" rel="noopener">Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT in this message
-
JCEM: The effect of testosterone therapy on male bone microstructure and bone density
Time of Update: 2021-03-26
gov/33693907/" target="_blank" rel="noopener">Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT .
gov/33693907/" target="_blank" rel="noopener">Effect of Testosterone treatment on bone microarchitecture and bone mineral density in men: a two-year RCT in this message
-
Winter sun less bone calcium easy to lose drink bone soup can supplement calcium?
Time of Update: 2021-01-22
Many patients believe that the winter sun less, bone calcium easy to lose lead to osteoporosis, bone brittle increase, so easy to fracture, so drink more bone soup calcium.
In this regard, Hunan Provincial People's Hospital orthopaedic director He Xuejun said that bone soup contains less calcium, milk, cheese, shrimp skin, sesame sauce, etc.
-
FDA approves Danyelza for bone or bone marrow recurrence or recurring neuroblastoma
Time of Update: 2020-12-15
danyelza can be used in combination with granulocyte macrophage collection stimulation factors (GM-CSF) in adult and child patients with bone or bone marrow recurrence or refrmmune high-risk neuroblastoma.
45 percent of the 22 patients treated in the study 201, 30 percent had DOR for six months or more, according to the FDA.
-
FDA approves Fulphila for non-bone marrow cancer patients undergoing bone marrow-inhibited chemotherapy
Time of Update: 2020-06-11
recently, the U.S FDA (approved Fulphila (pegfilgrastim-jmdb) for use in non-bone marrow cancer patients undergoing bone marrow inhibition chemotherapy to reduce the incidence of febrile neutropen
-
Biomater. SCI.: it is found that eggshell can help bone growth and treat bone damage
Time of Update: 2019-07-31
July 31, 2019 / BIOON / - a team of researchers at UMass Lowell found that eggshells can promote the growth of new and strong bones needed in medical operations Gulden CAMCI unal, assistant professor
-
Ebiomedicine: researchers have developed cancer treatments that target bone metastasis while preserving bone tissue
Time of Update: 2019-07-31
July 31, 2019 / BIOON / - researchers at the University of California, Irvine (UCI) have developed and tested a treatment method in mice that uses engineered stem cells to target and kill cancer metas
-
Epibone: bone culture with stem cells, a reduction of 900000 operations a year
Time of Update: 2014-11-14
Source: Lei Fengwang 2014-11-14 introduction: every year, about 900000 Americans will undergo bone related surgery, which is slow and painful Nina Tandon, a biomedical engineering student at Columbia
-
We found a protein to protect bone and protect bone health
Time of Update: 2012-04-25
Core tips: (reporter LAN Jianzhong) a research team led by Professor Gao Liuguang of Tokyo Medical and Dental University reported in the online edition of British Journal of nature on the 18th that th